Marvel Biosciences Corp. (MRVL.V)

CAD 0.16

(10.34%)

Annual Cash Flows

(In CAD)
Breakdown 2023 2022 2021 2020 2019
Operating Cash Flow -1.33 Million -2.19 Million -1.37 Million -538.53 Thousand -41.8 Thousand
Net Income -2.29 Million -2.55 Million -3.03 Million -955.65 Thousand -98.04 Thousand
Depreciation & Amortization - 152.00 185.00 413.00 -
Deferred income taxes - - - -421.1 Thousand -
Stock-based compensation 80.11 Thousand - - 384.44 Thousand -
Change in working capital 879.03 Thousand 360.05 Thousand -114.61 Thousand 32.26 Thousand 1072.00
Other non-cash items 105.59 Thousand -2364.00 1.78 Million 421.1 Thousand 57.17 Thousand
Investing Cash Flow - - 381.57 Thousand - -409 Thousand
Investments in PPE 5.00 - - - -
Acquisitions - - 381.57 Thousand - -
Investment purchases - - - - -409 Thousand
Sales/Maturities of investments - - - - -
Other Investing Activities - - - - -
Financing Cash Flow 1.29 Million 394 Thousand 3.15 Million 763.17 Thousand 457.03 Thousand
Debt repayment -1 Million - - - -
Dividends payments - - - - -
Common Stock Repurchased - - - - -
Common Stock Issuance 295.65 Thousand 420 Thousand 3.18 Million 758.42 Thousand 457.03 Thousand
Other Financing Activities 25.65 Thousand -26 Thousand -23.35 Thousand 4752.00 -
Accounts receivables -25.47 Thousand 2668.00 -23.26 Thousand -35.84 Thousand -2004.00
Accounts payables - - - - -
Inventory - - - - -
Other working capital 904.51 Thousand 357.38 Thousand -91.35 Thousand 68.1 Thousand 3076.00
Cash at beginning of period 593.2 Thousand 2.39 Million 224.81 Thousand 171.00 -
Cash at end of period 556.62 Thousand 593.2 Thousand 2.39 Million 224.81 Thousand 6232.00
Capital Expenditure 5.00 - - - -
Effect of forex changes on cash - - - - -
Net cash flow / Change in cash -36.58 Thousand -1.79 Million 2.16 Million 224.63 Thousand 6232.00
Free Cash Flow -1.33 Million -2.19 Million -1.37 Million -538.53 Thousand -41.8 Thousand

Cash Flow Charts